Brickell Biotech Earning Date (BBI)

USA |NASDAQ |USD

BBI Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 10, 2022 Jun 2022 - - $-0.16
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 10, 2022 Jun 2022 - - $151.00K

Brickell Biotech's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 2022.

BBI Earnings Date & History Chart

BBI Earnings & Revenue Forecast

BBI Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $-0.20 $-0.23 $-0.17

BBI Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 2 / 0 $-0.28 $-0.28 $-0.28

BBI Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $1.40M $0.00 $2.80M

BBI Earnings Date & Revenue History

BBI Earnings History

|
Show More
Show More

BBI Revenue History

|
Show More
Show More

Brickell Biotech Next Earnings Date & Report

BBI Next Earnings Date & Report Preview: Jun 2022 (FQ)

BBI's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 30, 2022.

Brickell Biotech Previous Earnings Dates & Reports

BBI Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Brickell Biotech's previous earnings date was May 11, 2022 for its fiscal quarter ended Mar 31, 2022.

BBI Previous Earnings Date & Report Recap: Dec 2021 (FY)

Brickell Biotech's previous annual earnings date was Mar 15, 2022 for its fiscal year ended Dec 31, 2021.

BBI's earnings per share (EPS) was $-0.53, missing the consensus analysts forecast of $-0.52 by 1.92% , and higher than the previous year's EPS (Dec 2020) by -55.23%.

Revenues were $404.00K, worse than the forecast of $450.00K by -10.22%, and down by -77.83% from previous year's revenue.

The company reported a net income of $-39.47M.

Brickell Biotech reported a free cash flow of $-36.18M for its fiscal year, compared to $-20.06M a year ago.